Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4750781
Max Phase: Preclinical
Molecular Formula: C14H22N5O7PS
Molecular Weight: 435.40
Molecule Type: Unknown
Associated Items:
ID: ALA4750781
Max Phase: Preclinical
Molecular Formula: C14H22N5O7PS
Molecular Weight: 435.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCSc1nc2c(N)ncnc2n1[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C14H22N5O7PS/c1-2-3-4-28-14-18-8-11(15)16-6-17-12(8)19(14)13-10(21)9(20)7(26-13)5-25-27(22,23)24/h6-7,9-10,13,20-21H,2-5H2,1H3,(H2,15,16,17)(H2,22,23,24)/t7-,9-,10-,13-/m1/s1
Standard InChI Key: VFLYSLPYKLFYSL-QYVSTXNMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 435.40 | Molecular Weight (Monoisotopic): 435.0978 | AlogP: 0.03 | #Rotatable Bonds: 8 |
Polar Surface Area: 186.07 | Molecular Species: ACID | HBA: 11 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.22 | CX Basic pKa: 4.60 | CX LogP: -1.94 | CX LogD: -3.21 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.21 | Np Likeness Score: 0.26 |
1. Jeffrey JL,Lawson KV,Powers JP. (2020) Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39., 63 (22): [PMID:32786396] [10.1021/acs.jmedchem.0c01044] |
Source(1):